LKFTLakefront Biotherapeutics NV - ADR

$27.66
$0.15
(0.55%)
Pre-Market
Updated: 07:45 AM EDT·Prev Close $27.51
Reported EarningsMay 6
Mkt Cap$1.81B
Vol500.00

About

Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
452

Frequently Asked Questions

What is Market Cap of Lakefront Biotherapeutics NV - ADR?
What is the 52-week high for Lakefront Biotherapeutics NV - ADR?
What is the 52-week low for Lakefront Biotherapeutics NV - ADR?
What is Lakefront Biotherapeutics NV - ADR stock price today?
What was Lakefront Biotherapeutics NV - ADR stock price yesterday?
What is the PE ratio of Lakefront Biotherapeutics NV - ADR?
What is the Price-to-Book ratio of Lakefront Biotherapeutics NV - ADR?
What is the 50-day moving average of Lakefront Biotherapeutics NV - ADR?
How many employees does Lakefront Biotherapeutics NV - ADR have?

Latest LKFT News

View
Top Discussions

Advertisement|Remove ads.